- Home
- SW vs WST Comparison
SW vs WST Comparison
Compare SW & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SW
- WST
- Stock Information
- Founded
- SW 1934
- WST 1923
- Country
- SW Ireland
- WST United States
- Employees
- SW N/A
- WST N/A
- Industry
- SW
- WST Medical/Dental Instruments
- Sector
- SW
- WST Health Care
- Exchange
- SW Nasdaq
- WST Nasdaq
- Market Cap
- SW 28.6B
- WST 23.2B
- IPO Year
- SW N/A
- WST N/A
- Fundamental
- Price
- SW $54.60
- WST $322.46
- Analyst Decision
- SW Buy
- WST Buy
- Analyst Count
- SW 7
- WST 3
- Target Price
- SW $58.57
- WST $460.33
- AVG Volume (30 Days)
- SW 3.4M
- WST 514.2K
- Earning Date
- SW 10-30-2024
- WST 10-24-2024
- Dividend Yield
- SW 2.22%
- WST 0.26%
- EPS Growth
- SW N/A
- WST N/A
- EPS
- SW 0.68
- WST 6.74
- Revenue
- SW $16,432,000,000.00
- WST $2,876,400,000.00
- Revenue This Year
- SW $147.85
- WST N/A
- Revenue Next Year
- SW $11.27
- WST $6.22
- P/E Ratio
- SW $80.34
- WST $47.61
- Revenue Growth
- SW 27.83
- WST N/A
- 52 Week Low
- SW $38.55
- WST $265.00
- 52 Week High
- SW $56.99
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- SW N/A
- WST 53.52
- Support Level
- SW N/A
- WST $313.92
- Resistance Level
- SW N/A
- WST $326.58
- Average True Range (ATR)
- SW 0.00
- WST 7.66
- MACD
- SW 0.00
- WST -0.61
- Stochastic Oscillator
- SW 0.00
- WST 84.86
About SW Smurfit WestRock plc Ordinary Shares
Smurfit WestRock manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. After the merger of Smurfit Kappa and WestRock in summer 2024, Smurfit WestRock became the largest producer of containerboard in the world, with substantial operations in North America, South America, and Europe.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.